Biznesradar bez reklam? Sprawdź BR Plus
Notowania JNJ.US
148.58-0.69(-0.46%)(czas lokalny: 06.05.2024 16:00)Johnson & Johnson
WERSJA BETA
New York Stock Exchange Inc
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Data: | |
---|---|
Kurs: | 148.58 |
Otwarcie: | 149.87 |
Min: | 147.91 |
Max: | 150.05 |
Wolumen: | 4 915 445 |
Min 52 tyg: | 143.13 |
Max 52 tyg: | 175.97 |
Zmiana | Zmiana % | Kurs odn. | Data odn. | |
---|---|---|---|---|
Zmiana 7d: | +2.44 | (+1.67%) | 146.14 | 26.04.2024 |
Zmiana 1m: | -3.81 | (-2.50%) | 152.39 | 05.04.2024 |
Zmiana 3m: | -7.22 | (-4.63%) | 155.80 | 05.02.2024 |
Zmiana YTD: | -8.16 | (-5.21%) | 156.74 | 29.12.2023 |
Zmiana 12m: | -14.10 | (-8.67%) | 162.68 | 05.05.2023 |
porównaj stopy zwrotu » |
WSKAŹNIKI AT
neutralnie
6 maj 22:00
mówią wskaźniki
RSI(14) | neutralnie |
STS(14,3) | kupuj |
MACD(12,26,9) | kupuj |
TRIX(14,9) | kupuj |
Williams %R(10) | sprzedaj |
interwał dzienny
zobacz więcej wskaźników »
SYGNAŁY AT
Williams %R < -20
|
2 maj 22:00 |
Williams %R > -80
|
1 maj 22:00 |
FI > 0
|
1 maj 22:00 |
TRIX > SIGNAL
|
1 maj 22:00 |
ROC > 0
|
1 maj 22:00 |
FI < 0
|
24 kwi 22:00 |
FI > 0
|
23 kwi 22:00 |
interwał dzienny
zobacz więcej sygnałów »
TRENDY
3m | Trend boczny | |
6m | Trend boczny | |
12m | Trend boczny | |
24m | Trend spadkowy | |
36m | Trend boczny |
STOPY ZWROTU
stopa zwrotu | w stosunku do S&P 500 | |
---|---|---|
1m | -2.50% | -2.06% |
3m | -4.63% | -9.45% |
6m | -1.82% | -20.71% |
12m | -8.67% | -33.97% |
24m | -15.94% | -40.87% |
36m | -11.07% | -35.38% |
OSTATNIE WIADOMOŚCI
Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health business last year, the company has been focused […]
The post Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion. The company reported net earnings of $5.3 billion, or $2.20 […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings increased 28% to $4.1 billion and EPS rose […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results first appeared on AlphaStreet.
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has enjoyed an edge over other players in the market due […]
The post Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect first appeared on AlphaStreet.
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical device businesses, on the heels of spinning off […]
The post Johnson & Johnson (JNJ) focuses on innovation after separating consumer business first appeared on AlphaStreet.
Dowiedz się więcej o wskaźnikach analizy technicznej i wykresach punktowo-symbolicznych.